Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Enliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes ...

Shares of ELVN opened at $22.47 on Friday. The firm has a market cap of $1.10 billion, a price-to-earnings ratio of -11.83 and a beta of 1.02. The stock has a 50 day moving average of $26.10 and a ...

What is the current share price of Enliven Therapeutics (ELVN)? Enliven Therapeutics's (ELVN) current share price is $24.07. This constitutes a price movement of 7.60% when compared to the share price ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Short interest in Enliven Therapeutics Inc (NASDAQ:ELVN) decreased during the last reporting period, falling from 6.91M to 6.87M. This put 33.18% of the company's publicly available shares short.

ELVN's initial phase 1 data for ELVN-001 in CML shows promising tolerability and activity in heavily pretreated patients, but the valuation remains high for a phase 1 company. ELVN-002 is in phase ...

Enliven Therapeutics' ELVN-001 shows promising interim data, achieving a 44% major molecular response rate in heavily pre-treated CML patients within 12 weeks. ELVN-001 targets the BCR-ABL gene ...

New Brand Reflects Company's Strategic Vision and Leadership in Internet Marketing Technology Solutions Market NEW YORK, Dec. 18 /PRNewswire-FirstCall/ -- Viewpoint ...